Omega 3, and CBD oils for medical and cosmetic industries. Non-animal testing of ingredients and skin-care, pharma, health and wound care products using AI data analytics. A vertically integrated laboratory to market environment with lab-grown human skin.
LabskinAnimal-Free Lab-grown, simulated human skin, for testing cosmetic and pharma products for dandruff, acne, fungal and bacterial infection
Innovenn Skin ScienceLabskin Certification of products, and training of Lab technicians. Virtual Lab services for cosmetic, skincare and pharma companies
Stoer For Men CosmeticsRange of skincare products derived from 5 natural super-ingredient plant extracts specifically for men to reduce the signs of aging
WoundPhaseVisual diagnostic wound dressing that changes colour to indicate infection or improvement of the wound under the dressing
Omega 3 from AlgaeMajor health benefits for global human population explosion. Alternative production to extraction from declining global fish stocks
Bio-Plastic IngredientsSolution to dumping 8 million tonnes of waste plastic in the oceans each year. Alternative biodegradable plastic solution
Algzym CBD TechnologyLow-cost Solvent-Free commercial scale solution to the production of Omega-3 oils from micro-algae and CBD oils from hemp
CellulacCommercial License Partners of the Algzym Technology platform for bio-based oils, including Omega 3, CBD and bio-plastic ingredients
There is more to skin care than good looking skin
Could your cosmetic containers be biodegradable? What about your face-scrub? Are you flushing plastic microbeads down the drain into the oceans for fish to eat?
What about the oils you put on your face? Are they natural plant extracts or by-products of fossil fuels?
Integumen license production from agricultural feedstocks and natural grown plant-extracts. We convert them to natural oils and ingredients for nutritional foods and cosmetics. We test them on our own non-animal-testing lab-grown human skin to clinically prove they work for you.
Meet Our Team
Gerard J Brandon CEOGerard is a seasoned international executive and serial entrepreneur, joining Cellulac as its CEO in May 2012. In 1996 he co-founded, as CEO, Alltracel Pharmaceuticals plc, which completed an IPO on AIM in 2001 and was subsequently acquired in 2008. In 2004 Gerard was appointed Managing Partner for Farmabrand Private Equity. He is an author and Fellow of the Ryan Academy of Entrepreneurs in Dublin.
Camillus Glover COOCamillus joined Cellulac as CFO in May 2012 and is a Chartered Accountant Institute member since 1985, qualifying with KPMG. He moved from his position as Operations Director at Campbell Bewley Group to be Chief of Operations at Alltracel Pharmaceuticals plc in 2003 and later stayed on after being acquired by Hemcon Medical Technologies as VP Global Business Development, 2009-2012.
Tony Richardson - ChairTony is the non-executive chairman of Integumen while also CEO of Venn Life Sciences. He was previously Co-Founder and CEO of Alltracel Pharmaceuticals. A Fellow of the Association of Chartered Certified Accountants and has held key leadership positions in a number of Medical Technology companies and has accumulated considerable transaction experience including IPO, financings and M&A
Your Connection Starts Here
Or call — +44 (20) 3239 3716